{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:27:28Z","timestamp":1792114048836,"version":"4.4.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH112237"],"award-info":[{"award-number":["MH112237"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007429","name":"Nancy Lurie Marks Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.neuropharm.2021.108893","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T01:40:57Z","timestamp":1637545257000},"page":"108893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Inhibition of histone deacetylase 5 ameliorates abnormalities in 16p11.2 duplication mouse model"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9202-4469","authenticated-orcid":false,"given":"Benjamin","family":"Rein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9996-0786","authenticated-orcid":false,"given":"Megan","family":"Conrow-Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allea","family":"Frazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2021.108893_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature12743","article-title":"The activity-dependent transcription factor NPAS4 regulates domain-specific inhibition","volume":"503","author":"Bloodgood","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108893_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13229-020-00387-6","article-title":"High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons","volume":"11","author":"Cavallo","year":"2020","journal-title":"Mol. Autism."},{"key":"10.1016\/j.neuropharm.2021.108893_bib3","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.2174\/1381612823666171024130001","article-title":"Role of histone deacetylases (HDACs) in epilepsy and epileptogenesis","volume":"23","author":"Citraro","year":"2017","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.neuropharm.2021.108893_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fnana.2015.00145","article-title":"Expression of Npas4 mRNA in telencephalic areas of adult and postnatal mouse brain","volume":"9","author":"Damborsky","year":"2015","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.neuropharm.2021.108893_bib5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.0013-9580.2004.00104.x","article-title":"The activity of antiepileptic drugs as histone deacetylase inhibitors","volume":"45","author":"Eyal","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108893_bib6","doi-asserted-by":"crossref","first-page":"17076","DOI":"10.1073\/pnas.1114042108","article-title":"Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism","volume":"108","author":"Horev","year":"2011","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.neuropharm.2021.108893_bib7","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2021.108893_bib8","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nature07319","article-title":"Activity-dependent regulation of inhibitory synapse development by Npas4","volume":"455","author":"Lin","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108893_bib9","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/s41386-018-0073-1","article-title":"Histone deacetylase inhibitor MS-275 restores social and synaptic function in a Shank 3-deficient mouse model of autism","volume":"43","author":"Ma","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108893_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10020109","article-title":"Chronic chemogenetic stimulation of the nucleus accumbens produces lasting reductions in binge drinking and ameliorates alcohol-related morphological and transcriptional changes","volume":"10","author":"Pozhidayeva","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuropharm.2021.108893_bib11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41593-018-0110-8","article-title":"Social deficits in Shank 3-deficient mouse models of autism are rescued by histone deacetylase (HDAC) inhibition","volume":"21","author":"Qin","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108893_bib12","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1038\/s41596-020-0382-9","article-title":"A standardized social preference protocol for measuring social deficits in mouse models of autism","volume":"15","author":"Rein","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2021.108893_bib13","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/s41380-020-0693-9","article-title":"Reversal of synaptic and behavioral deficits in a 16p11.2 duplication mouse model via restoration of the GABA synapse regulator Npas4","volume":"26","author":"Rein","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108893_bib14","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.tins.2020.09.001","article-title":"16p11.2 copy number variations and neurodevelopmental disorders","volume":"43","author":"Rein","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108893_bib15","article-title":"Role of altered expression, activity and sub-cellular distribution of various histone deacetylases (HDACs) in mesial temporal lobe epilepsy with hippocampal sclerosis","author":"Srivastava","year":"2020","journal-title":"Cell Mol Neurobiol, Epub ahead of print"},{"key":"10.1016\/j.neuropharm.2021.108893_bib16","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/schbul\/sby163","article-title":"Stress exposure in dopamine D4 receptor knockout mice induces schizophrenia-like behaviors via disruption of GABAergic transmission","volume":"45","author":"Tan","year":"2019","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2021.108893_bib17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuron.2017.09.015","article-title":"HDAC5 and its target gene, Npas4, function in the nucleus accumbens to regulate cocaine-conditioned behaviors","volume":"96","author":"Taniguchi","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108893_bib18","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1093\/hmg\/ddw231","article-title":"HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder","volume":"25","author":"Trazzi","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2021.108893_bib19","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1523\/JNEUROSCI.0149-18.2018","article-title":"Chemogenetic activation of prefrontal cortex rescues synaptic and behavioral deficits in a mouse model of 16p11.2 deletion syndrome","volume":"38","author":"Wang","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108893_bib20","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/s41386-021-01029-y","article-title":"Autism risk gene KMT5B deficiency in prefrontal cortex induces synaptic dysfunction and social deficits via alterations of DNA repair and gene transcription","volume":"46","author":"Wang","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108893_bib21","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1038\/s41380-019-0351-2","article-title":"Amelioration of autism-like social deficits by targeting histone methyltransferases EHMT1\/2 in Shank 3-deficient mice","volume":"25","author":"Wang","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108893_bib22","article-title":"Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications","author":"Yan","year":"2021","journal-title":"Mol Psychiatry, Epub ahead of print"},{"key":"10.1016\/j.neuropharm.2021.108893_bib23","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.neuron.2011.12.033","article-title":"Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex","volume":"73","author":"Yuen","year":"2012","journal-title":"Neuron"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821004482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821004482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:13:50Z","timestamp":1758438830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390821004482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":23,"alternative-id":["S0028390821004482"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108893","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of histone deacetylase 5 ameliorates abnormalities in 16p11.2 duplication mouse model","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108893"}}